Based on data from the past 90 days ending February 19, 2026, Champions Oncology's three largest insider shareholders are Director Joel Ackerman (1.06Mn shares), Ceo Ronnie Morris (858.88K shares), Director David Sidransky (767.04K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Joel Ackerman | 1,056,539 | 06 Nov, 2025 | |
| Ronnie Morris | Ceo | 858,878 | 21 Mar, 2023 |
| David Sidransky | 767,043 | 14 Oct, 2022 | |
| Daniel Newman Mendelson | 198,625 | 16 Jan, 2024 | |
| Scott R Tobin | 30,000 | 13 Oct, 2022 | |
| Philip P. Breitfeld | 5,717 | 02 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Oct, 2025 | Joel Ackerman | Common Stock | A | 94,405 | $2.10 | 1,056,539 | D | M |
| 25 Mar, 2025 | Philip P. Breitfeld | - | - | 5,717 | D | |||
| 25 Mar, 2025 | Philip P. Breitfeld | Common Stock | D | 4,150 | $0.00 | 5,717 | D | J |
| 31 Oct, 2024 | Joel Ackerman | - | - | 945,467 | D | |||
| 31 Oct, 2024 | Joel Ackerman | - | - | 962,134 | D | |||
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 16,667 | $5.43 | 962,134 | D | M |
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 88,470 | $2.10 | 945,467 | D | M |
| 12 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 1,000 | $6.50 | 198,625 | D | P |
| 11 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 2,000 | $6.27 | 197,625 | D | P |
| 10 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 2,944 | $6.31 | 195,625 | D | P |
| 09 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 3,000 | $6.25 | 192,681 | D | P |
| 08 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 1,000 | $6.15 | 189,681 | D | P |
| 05 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 2,000 | $6.09 | 188,681 | D | P |
| 04 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 3,000 | $6.12 | 186,681 | D | P |
| 03 Jan, 2024 | Daniel Newman Mendelson | - | - | 183,681 | D | |||
| 03 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 500 | $5.83 | 183,681 | D | P |
| 21 Dec, 2023 | Daniel Newman Mendelson | Common Stock | A | 2,500 | $4.92 | 183,181 | D | P |
| 20 Dec, 2023 | Daniel Newman Mendelson | Common Stock | A | 2,100 | $4.82 | 180,681 | D | P |
| 19 Dec, 2023 | Daniel Newman Mendelson | Common Stock | A | 5,000 | $4.75 | 178,581 | D | P |
| 11 Oct, 2023 | Daniel Newman Mendelson | Common Stock | A | 5,000 | $6.40 | 163,081 | D | P |